GLPG
NASDAQ
BE
Galapagos NV - American Depositary Shares
$29.42
▼ $-0.34
(-1.14%)
Vol 176K
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$1.8B
ROE
-16.2%
Margin
-55.0%
D/E
0.31
Beta
0.89
52W
$20–$33
Wall Street Consensus
18 analysts · Apr 20262
Strong Buy
1
Buy
6
Hold
6
Sell
3
Strong Sell
16.7%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 25.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Dec 2025 | $2.76 | $11.87 | +$9.11 |
| Sep 2025 | $-0.02 | $-3.07 | $-3.05 |
| Jun 2025 | $-0.09 | $-1.60 | $-1.51 |
| Mar 2025 | $-0.20 | $-2.33 | $-2.13 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… |
|---|---|---|---|---|---|
| Revenue | $59.8M | $75.5M | $75.0M | $65.3M | $71.2M |
| Net Income | -$50.4M | $25.3M | -$153.4M | -$105.7M | -$202.1M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -10.2% | -4.7% | -4.7% | -4.7% | -16.2% | -16.2% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | -162.4% | -55.0% | -55.0% | -55.0% | -55.0% | -55.0% |
| Gross Margin | 92.8% | 46.7% | 46.7% | 46.7% | 46.7% | 46.7% |
| D/E Ratio | 0.32 | 0.32 | 0.32 | 0.32 | 0.31 | 0.31 |
| Current Ratio | 8.08 | 8.08 | 8.08 | 8.08 | 8.62 | 8.62 |
Key Ratios
ROA (TTM)
-11.3%
P/S (TTM)
3.57
P/B
0.6
EPS (TTM)
$-6.61
CF/Share
$-2.87
Rev Growth 3Y
-16.3%
52W High
$32.74
52W Low
$20.00
$20.00
52-Week Range
$32.74
Financial Health
Free Cash Flow
-$65.5M
Net Debt
-$57.0M
Cash
$64.5M
Total Debt
$7.5M
As of Sep 30, 2025
How does GLPG compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
GLPG valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
3.6
▼
72%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.6
▼
75%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
GLPG profitability vs Biotechnology peers
ROE
-16.2%
▲
76%
above
peers
(-67.3%)
vs Peers
vs Industry
Top tier
Net margin
-55.0%
▲
81%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
46.7%
▼
41%
below
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-11.3%
▲
76%
above
peers
(-46.7%)
vs Peers
vs Industry
Top tier
GLPG financial health vs Biotechnology peers
D/E ratio
0.3
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
In line
Current ratio
8.6
▲
94%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▼
9%
below
peers
(1.0)
vs Peers
vs Industry
Less volatile
GLPG fundamentals radar
GLPG
Peer median
Industry
GLPG profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
GLPG vs peers: key metrics
Top Holders
Top 5: 39.39%Gilead Sciences Inc
25.35%
$485.9M
Tang Capital Management, LLC
5.95%
$114.0M
Madison Avenue Partners, LP
3.36%
$64.4M
EcoR1 Capital, LLC
2.53%
$48.5M
Ameriprise Financial, Inc.
2.20%
$42.2M
As of Dec 31, 2025